EFFICACY AND SAFETY OF GOLIMUMAB INDUCTION FOR MODERATE TO SEVERE ULCERATIVE COLITIS IN THE UNITED KINGDOM: RESULTS FROM THE GOCOLITIS STUDY

被引：0
|
作者：
Probert, C. [1 ]
Gaya, D. [2 ]
Hamlin, P. J. [3 ]
Irving, P. [4 ]
Sebastian, S. [5 ]
Gillespie, G. [6 ]
Tate, H. [6 ]
Wheeler, C. [6 ]
机构：
[1] Univ Liverpool, Liverpool, Merseyside, England
[2] Glasgow Royal Infirm, Glasgow, Lanark, Scotland
[3] Leeds Teaching Hosp Trust, Leeds, W Yorkshire, England
[4] Guys & St Thomas Hosp, London, England
[5] Hull & East Yorkshire NHS Trust, Kingston Upon Hull, N Humberside, England
[6] MSD UK, Hoddesdon, England
来源：
GUT | 2016年 / 65卷
关键词：
D O I：
10.1136/gutjnl-2016-312388.3
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
OC-003
引用
收藏
页码：A2 / A3
页数：2
相关论文
共 50 条
  • [1] EFFICACY AND SAFETY OF GOLIMUMAB INDUCTION FOR MODERATE TO SEVERE ULCERATIVE COLITIS IN THE UNITED KINGDOM: RESULTS FROM THE GO-COLITIS
    Probert, C.
    Gaya, D.
    Hamlin, P. J.
    Irving, P.
    Sebastian, S.
    Gillespie, G.
    Tate, H.
    Wheeler, C.
    [J]. GUT, 2017, 66 : A8 - A8
  • [2] Efficacy and safety of golimumab induction for moderate-to-severe ulcerative colitis in the United Kingdom: results from the GO-COLITIS study
    Probert, C.
    Gaya, D. R.
    Hamlin, P. J.
    Irving, P.
    Sebastian, S.
    Gillespie, G.
    Tate, H.
    Wheeler, C.
    [J]. JOURNAL OF CROHNS & COLITIS, 2016, 10 : S57 - S58
  • [3] PATIENT-REPORTED QUALITY OF LIFE DURING GOLIMUMAB INDUCTION FOR MODERATE TO SEVERE ULCERATIVE COLITIS IN THE UNITED KINGDOM: RESULTS FROM THE GO-COLITIS STUDY
    Irving, P.
    Probert, C.
    Gaya, D.
    Hamlin, P. J.
    Sebastian, S.
    Gillespie, G.
    Tate, H.
    Wheeler, C.
    [J]. GUT, 2016, 65 : A87 - A87
  • [4] Patient-reported quality of life during golimumab induction for moderate-to-severe ulcerative colitis in the United Kingdom: results from the GO-COLITIS study
    Irving, P.
    Probert, C.
    Gaya, D. R.
    Hamlin, P. J.
    Sebastian, S.
    Gillespie, G.
    Tate, H.
    Wheeler, C.
    [J]. JOURNAL OF CROHNS & COLITIS, 2016, 10 : S250 - S251
  • [5] Golimumab for moderate to severe ulcerative colitis
    Strik, Anne S.
    Berends, Sophie E.
    Mathot, Ron A.
    D'Haens, Geert R.
    Lowenberg, Mark
    [J]. EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2017, 11 (05) : 401 - 406
  • [6] Golimumab induction and maintenance for moderate to severe ulcerative colitis: results from GO-COLITIS (Golimumab: a Phase 4, UK, open label, single arm study on its utilization and impact in ulcerative Colitis)
    Probert, Christopher S. J.
    Sebastian, Shaji
    Gaya, Daniel R.
    Hamlin, P. John
    Gillespie, Gillian
    Rose, Anita
    Tate, Helen
    Wheeler, Colin
    Irving, Peter M.
    Probert, C.
    Gaya, D.
    Sebastian, S.
    Hart, A.
    Irving, P.
    Ahmad, T.
    Pollok, R.
    Orchard, T.
    Arasaradnam, R.
    Iqbal, T.
    Johnson, M.
    Kaser, A.
    Allen, P.
    Gordon, J.
    Preston, C.
    Shenderey, R.
    Hoque, S.
    Bloom, S.
    Ansari, A.
    Mowat, C.
    Hamlin, J.
    Arnott, I
    Shaw, I
    Steed, H.
    Butterworth, J.
    Robinson, A.
    Mawdsley, J.
    Creed, T.
    Cummings, F.
    [J]. BMJ OPEN GASTROENTEROLOGY, 2018, 5 (01):
  • [7] GOLIMUMAB INDUCTION FOR MODERATE TO SEVERE ULCERATIVE COLITIS: PATIENT-REPORTED OUTCOMES OF PARTIAL MAYO SCORE RESULTS FROM THE GO-COLITIS STUDY
    Sebastian, S.
    Probert, C.
    Gaya, D.
    Hamlin, P. J.
    Irving, P.
    Gillespie, G.
    Tate, H.
    Wheeler, C.
    [J]. GUT, 2017, 66 : A122 - A123
  • [8] Efficacy and safety of ustekinumab through Week 16 in patients with moderate to severe ulcerative colitis: Results from the UNIFI induction trial
    Danese, S.
    Sands, B.
    O'Brien, C.
    Zhang, H.
    Johanns, J.
    Sloan, S.
    Izanek, J.
    Szapary, P.
    Marano, C.
    Leong, R.
    Rowbotham, D.
    Targan, S.
    Van Assche, G.
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 130 - 131
  • [9] Pharmacokinetics of golimumab in moderate to severe ulcerative colitis: the GO-KINETIC study
    Berends, Sophie E.
    Strik, Anne S.
    Jansen, Jeroen M.
    de Boer, Nanne K.
    van Egmond, Pleun S.
    Brandse, Johannan F.
    Mathot, Ron A.
    D'Haens, Geert R.
    Lowenberg, Mark
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2019, 54 (06) : 700 - 706
  • [10] Efficacy and safety of the adalimumab biosimilar Exemptia as induction therapy in moderate-to-severe ulcerative colitis
    Midha, Vandana
    Mahajan, Ramit
    Mehta, Varun
    Narang, Vikram
    Singh, Arshdeep
    Kaur, Kirandeep
    Sood, Ajit
    [J]. INTESTINAL RESEARCH, 2018, 16 (01) : 83 - 89
12345